- Poster Session
Posters 12: Neurogenic Bladder, GU Trauma and Reconstruction

Sunday June 26, 2022 | 07:30 to 09:00
Room: Aspen

Learning Objectives

As a result of attending this session, participants will be able to:

  • Understand new management strategies for correction of urethral stricture disease
  • Be familiar with selection criteria of patients receiving ambulatory urethroplasty surgery
  • Be aware of recent developments in the fields of urinary diversion, sacral nerve modulation, neurogenic bladder risk stratification, female urethral strictures, and surgical management of complex reconstructive patients


Presentations



MP-12.1

Dr. / Dr Keith F. Rourke
Defining the optimal management of lichen sclerosus induced penile urethral strictures: a comparison of single-stage urethroplasty, staged urethroplasty and perineal urethrostomy


08:04
MP-12.3

Dr. / Dr Sender Herschorn
Urinary tract reconstruction with enterocystoplasty after radiation for pelvic cancer



MP-12.4

Mr. / M. Mark A McAllister
Comparative evaluation of patient outcomes following extended day surgery urethroplasty at a Canadian tertiary care centre


08:12
MP-12.5

Dr. / Dr Mostafa M. Mostafa
The outcomes of urinary diversion for neurogenic vs non-neurogenic bladder dysfunction: 10 years single center experience


08:16
MP-12.6

Dr. / Dr Mélanie Aubé-Peterkin
Long-term followup from the ROBUST III study: Interim two-year results


08:20
MP-12.7

Dr. / Dr Walid Shahrour
Ambulatory Buccal Mucosal Graft urethroplasty in geriatric population: comparative study


08:24
MP-12.8

Miss / Mlle Jordyn Shaw
Dorsal onlay buccal mucosal graft for female urethral stricture: clinical and patient reported outcome measures


08:28
MP-12.9

Dr. / Dr Laurianne Rita Garabed
Complex buccal graft urethroplasty combined with HoLEP in the setting of concomitant urethral stricture disease and benign prostatic hyperplasia


08:32
MP-12.11

Dr. / Dr Haider Abed
An initial evaluation of the CUA Neurogenic Bladder Guidelines risk stratification


08:36
MP-12.12

Dr. / Dr Mostafa M. Mostafa
The long-term outcomes of cathterizable stoma vs incontinent urine diversion for lower urinary tract dysfunction



UP-12.1

Dr. / Dr Dean Elterman
Novel rechargeable sacral neuromodulation system improves quality of life in overactive bladder subjects at 3-month follow up in a global, prospective, post-market study




© 2024 CUA 77th Annual Meeting